Ambien Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

A Study to Determine the Abuse Potential of Single Oral Doses of Lemborexant Compared to Zolpidem, Suvorexant and Placebo in Healthy, Non-Dependent, Recreational Sedative Users
Condition:   Insomnia Disorders Interventions:   Drug: Zolpidem tablets;   Drug: Suvorexant tablets, over-encapsulated;   Drug: Lemborexant tablets;   Drug: Placebo lemborexant;   Drug: Placebo zolpidem;   Drug: Placebo suvorexant Sponsors:   Eisai Inc.;   Purdue Pharma LP Recruiting - verified May 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2017 Category: Research Source Type: clinical trials